A development stage biopharmaceutical company.
Business Model:
Revenue: $0
Employees: 1-10
Address:
City: Vernon Hills
State: Illinois
Zip:
Country: United States
Applied NeuroSolutions, Inc., a development stage biopharmaceutical company, focuses on the development of therapeutic targets for the treatment of Alzheimer&s;s disease (AD) and diagnostics to detect AD. It also develops cerebrospinal fluid-based and serum-based tests to detect AD at an early stage. The company also markets a transgenic mouse comprising the human tau gene that develops human paired helical filaments, the building blocks of the neurofibrillary tangles, which are involved in the pathology of Alzheimer’s disease; and provides diagnostic services to pharmaceutical companies. Ophidian Pharmaceuticals is a division of Applied NeuroSolutions Inc. Source: [Bloomberg Businessweek]
Contact Phone:
Contact Email:
Listed Exchange:
OTCBB
IPO Date:
5/7/1998
Ticker Symbol:
OPHD
IPO Price:
$6.1/share
Amount Raised:
$11M
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|